Ai Virtual Agent Selection, Implementation and Support Keys to Success
Improving Population Health via Non-traditional Partnerships
Efficient Data Management in the Healthcare Space
Transform Healthcare with a Passion for Innovation
Significant technological change often means a cultural shift for...
NovletMattis, Chief Information Officer, Orlando Health
Disrupting the CIO Comfort Zone to Innovate and Transform How...
Wes Williams, VP & CIO, Mental Health Center Of Denver
Bringing the Worlds of Technology and Health Closer to Each Other
Kristin Myers, Chief Information Officer, Mount Sinai Health System
The Biopsychosocial Model: The Future of Remote Patient Monitoring
Heather Comerci Reyes, Md, Me; Michael Hasselberg, Phd, Chief Digital Health Officer, University Of Rochester Medical Center
Thank you for Subscribing to CIO Applications Weekly Brief
Advera Health Analytics, a leader in pharmacovigilance, has been acquired by TriNetX.
The goal of the world's biggest real-world data network is to improve medication safety.
Fremont, CA: "Life sciences companies trust Advera for safety signal detection and management," said Brian M. Overstreet, President and CEO of Advera, who will now lead the pharmacovigilance business unit at TriNetX as a senior executive and member of the company's leadership team. "The Evidex platform enables drug safety teams to quickly validate signals through advanced technology, multiple safety datasets, and integrated workflow management tools. Evidex's adoption in the market has led to significant progress in the evolution of pharmacovigilance."
TriNetX is a global system of healthcare organizations and life sciences businesses accelerating the discovery of innovative medicines through real-world research. TriNetX's self-service, HIPAA, GDPR, and LGPD-compliant platform of federated EHR, datasets, and consultancy relationships empowers its global community to enhance protocol design, simplify trial operations, optimize safety signals, and enrich real-world evidence gathering.
TriNetX obtained Advera Health Analytics, the market leader in pharmacovigilance software applications, to identify, manage, and mitigate drug safety risks.
Advera's purchase, together with its industry-leading Evidex technology, will provide TriNetX clients with a comprehensive picture of drug safety concerns as they occur in real-time. The power of Evidex, as well as the large amount of real-world data on the TriNetX network, will assist life sciences businesses in refining, managing, and validating safety signals with deeper clinical data and more efficient than the sector has previously depended on.
Advera Health Analytics is a global pioneer in pharmacovigilance software, analytics, and data at the forefront of drug safety science. Advera Health developed Evidex, a next-generation pharmacovigilance platform that connects diverse drug safety data sources and provides a user experience that extracts actionable knowledge from that data.